Original Contributions |
From the SUNY/Health Science Center (G.C., S.M.T., M.D.), Syracuse, NY; the Molecular Biology and Virology Laboratory (M.K.), The Salk Institute, La Jolla, Calif; and the Cancer Research Center (A.F.L.), University of Hawaii at Manoa, Honolulu, Hawaii.
Correspondence to Mario Delmar, MD, PhD, Department of Pharmacology, SUNY Health Science Center, 766 Irving Ave, Syracuse, NY 13210. E-mail delmarm{at}vax.cs.hscsyr.edu
| Abstract |
|---|
|
|
|---|
Key Words: connexin gap junction peptide proline-rich peptide cardiac arrhythmia Xenopus oocyte
| Introduction |
|---|
|
|
|---|
Earlier studies from our laboratory showed that truncation of the CT region of Cx43 impaired pH gating.13 More recently, we have shown that acidification-induced closure of Cx43 results from an interaction between the CT domain and a separate region of connexin.14 The data have led us to a particle-receptor model, similar to the ball-and-chain model of voltage-dependent gating of nonjunctional channels.15 16 The interaction between regions of connexin may occur through intermediary molecules.
We have conducted a thorough survey of the regions of the CT domain
that are necessary for pH gating.17 Of particular
interest was the observation that amino acids within region 261 to 300
were essential in this process.17 This segment is
rich in proline residues. A repeat (PXXP)3 is
found between amino acids 274 and 283. Moreover, mutation of prolines
277 and 280 interfered with the normal acidification-induced
uncoupling.17 Proline-rich sequences commonly
form left-handed
helices18 19 and are often
involved in protein-protein interactions.18 19 20 21
The ability of proline-rich regions to interact with other proteins is
sequence specific, and the interaction involves not only the proline
backbone but the flanking amino acids as
well.18 19 21 We hypothesized that the
proline-rich region of the Cx43 CT is implicated in a binding reaction
that is critical for acidification-induced channel closure.
Accordingly, pH gating should be blocked by a peptide of a sequence
that is analogous to that of the proline-rich region. The experiments
reported in the present study were designed to test the latter
hypothesis. The data show that a synthetic 17mer peptide formed by
amino acids 271 to 287 of Cx43
(CSSPTAPLSPMSPPGYK)22 23 interfered, in a
sequence-specific manner, with acidification-induced uncoupling of
Cx43. This is the first demonstration of a small molecule that can
disrupt the chemical regulation of Cx43 channels. Our studies open the
door for the development of other peptidic, or peptidomimetic,
molecules that could selectively block the function of native gap
junctions. Such a tool would be invaluable for studying the role of gap
junction regulation in both health and disease.
| Materials and Methods |
|---|
|
|
|---|
Recording of Gj and pHi
Gj was measured
electrophysiologically using a conventional
dual two-electrode voltage-clamp circuit. Only cells with resting
potentials more negative than -40 mV were used for the study.
pHi was detected using the pH-sensitive
fluorophore dextran-SNARF-1. The dye was injected into the cells
simultaneously with the Cx43 mRNA. For recording,
cells were placed on the stage of an inverted microscope.
Microelectrode impalements were obtained from above the stage while
pHi measurements were recorded from below
using conventional epifluorescence
techniques.14 24 SNARF-1 was excited with
monochromatic light at a wavelength of 534 nm. The emitted light was
collected at two separate wavelengths (590 and 630 nm). The ratio of
emitted light intensity at 590 nm to that at 640 nm was used as an
indicator of pHi. A detailed description of the
hardware and software used as well as the calibration procedures to
convert the optical ratio values to pHi units can
be found in previous publications from our
laboratory.14 17 24 25
pHi Versus Gj (or "pH Sensitivity Curves")
The relation between Gj and pHi (ie,
pHi-Gj curves) was studied by changing pH in a
ramplike fashion, as previously described.14 24
Cells were superfused with a solution of the following composition
(mmol/L): NaCl 72.5, KCl 1, MgSO4 0.82,
CaCl2 0.74, and NaHCO3 18.
Solutions were saturated with a gas mixture containing
CO2. The pH of the superfusate was
determined by the proportion of CO2 used for
gassing the solution, as well as by the concentration of
NaHCO3 in the superfusate, according to
the Henderson-Hasselbalch equation. The concentration of
CO2 in the superfusate was increased in a
ramplike fashion by means of a programmable
valve.14 24 The proportion of
CO2/O2 in the outlet of the
valve was controlled by a computer program. Our previous experience
shows that by using slow, progressively increasing acidification ramps,
the time course and extent of acidification is highly reproducible
between experiments.25 Moreover, using slow
acidification ramps, we have shown that the changes in Gj directly
follow the changes in pHi, so that direct
point-by-point correlations between Gj and pHi
can be established.14 25
Peptide Preparation
A list of the peptides tested and their amino acid sequences is
provided in Table 1
. The
production of the 17mer peptide has been described
before.22 Other short peptides were purchased
from a commercial supplier (Genemed Inc). All peptides were assessed
chromatographically and determined to be >95% pure. A
polypeptide of the CT domain (amino acids 241 to 382, referred to as
Cx43CT) was generated from Escherichia coli transformed with
a fusion construct of GST in frame with Cx43CT linked by a thrombin
cleavage site. The construct was generated by polymerase chain
reaction, followed by subcloning into pGEX-2T (Pharmacia). In order to
maintain the fidelity of the sequence, pfu polymerase
(Stratagene) was used for the amplification. The fidelity was then
confirmed by DNA sequencing. Plasmids were transformed into E
coli, and fusion proteins were prepared from bacterial extracts of
DH5-
(Gibco BRL) 3 hours after induction with
isopropylthio-ß-galactoside. The GST-Cx43CT fusion protein was
purified using glutathione-coated Sepharose beads, and the Cx43CT was
cleaved from the GST by thrombin. An aliquot of the Cx43CT polypeptide
was assessed by SDS-PAGE and Coomassie blue staining to determine its
purity and concentration. All peptides were diluted in pure water.
|
Peptide Injection
The peptide-containing solution was loaded into a micropipette
and injected into both oocytes of a pair using the same technique as
for mRNA injection. Cells were injected 20 to 30 minutes before the
onset of recording. Total injected volume was 25 to 50 nL per
cell. In all cases, the estimated peptide concentration inside each
cell was 20 to 40 µmol/L.
Data Analysis
Between 6 and 11 oocyte pairs were used for each curve. Only
oocyte pairs with Gj values below 10 µS were used for the study. For
each pair, Gj values during acidification were normalized to the
maximum value of Gj recorded. A curve was obtained from the best
fit of all experimental data collected within a single experiment by
using a Hill equation. The value of pH at which Gj decreased to 50%
from maximum was referred to as the pKa. With our experimental
procedure, a value of pKa was collected from each individual
experiment. An average pKa was estimated from all individual pKa values
collected within an experimental group. In a few experiments, Gj
decreased only to
60% from maximum. In those cases, the data were
fit with a Hill equation, and the curve was extrapolated to
Gj/Gjmax of 0.5. To determine whether pH
sensitivity had been altered after a particular treatment, statistical
comparisons of the pKa and Hill coefficient values were conducted using
ANOVA and Bonferroni tests.14 17 Changes in Hill
coefficient resulting from the experimental manipulations reported in
the present study should be interpreted with caution (see
"Discussion").
| Results |
|---|
|
|
|---|
|
|
The open circles in Figure 1A
show data obtained from Cx43-expressing
oocytes that were injected, 20 minutes before the onset of
recording, with 50 nL of water. The results show that the
injection procedure per se did not affect the susceptibility of Cx43 to
acidification-induced uncoupling. The pKa of the average curve
recorded from 8 oocyte pairs that were injected with water alone
was 6.73±0.06. This value is within the variability that we have
detected from noninjected oocytes.14 17
Injection of a Peptide With Sequence 321 to 337 of Cx43
The study of Ek-Vitorin et al17 showed that
10 to 20 amino acid deletions from the region 300 to 374 did not
significantly modify pH sensitivity. As a further control for our
experiments, we tested whether a synthetic peptide of a sequence
corresponding to region 321 to 337 of Cx43 (data labeled p321-337)
could alter pH gating. Results are shown in Figure 1B
. Open circles
show data obtained from oocytes that were injected with 20 to 30
µmol/L of p321-337 (total injected volume was 25 nL; n=8). The
injection was carried out 20 minutes before the onset of
recording. Clearly, injection of p321-337 did not modify the pH
sensitivity of Cx43 (pKa 6.67±0.08). These results demonstrate that
the injection procedure and the addition of a nonspecific peptide
molecule are not, by themselves, capable of altering pH gating.
Effect of Excess Cx43CT on the pH Gating of Cx43 Channels
As a first approach in studying the effect that an excess of
relevant CT sequences can have on the pH gating of wild-type Cx43, both
oocytes of a connexin-expressing pair were injected with a polypeptide
corresponding to amino acids 241 to 382 of Cx43. This polypeptide
(Cx43CT) was cleaved from the GST-Cx43CT fusion protein expressed in
bacteria (see "Materials and Methods"). Figure 2
shows the results. Solid circles depict
data from Cx43-expressing oocytes that were not injected; open circles
show data from oocytes injected, 20 to 30 minutes before
recording, with the CT fragment (30 µmol/L). Clearly,
the presence of the CT domain interfered with the pH gating reaction.
pKa was 6.43±0.05 in the presence of the CT fragment (n=6). This value
was significantly different from that recorded from noninjected
oocytes (P<0.001). The values of the Hill coefficient were
not statistically different.
|
The 17mer Peptide Impairs pH Gating of Cx43
Previous studies have shown that amino acids within region 261 to
300 of Cx43 are involved in several regulatory
functions,22 23 including pH
gating.17 Therefore, we tested whether a 17mer
peptide from this region (amino acids 271 to 287 of Cx43) could mimic
the results obtained from injection of a polypeptide from the entire
Cx43CT domain. As shown in Figure 3
, injection of the 17mer peptide greatly impaired the ability of Cx43
channels to close on acidification. Panel A shows the
simultaneous measurements of Gj (top) and
pHi (bottom) recorded from one experiment in
which 30 µmol/L of the 17mer peptide had been injected 20
minutes before the onset of recording. Intracellular
acidification progressed in a ramplike fashion, going from a control
value of 7.1 to 6.4 in
40 minutes. Gj showed an initial increase at
the onset of acidification. This increase has been previously reported,
and its possible nature has been extensively discussed in previous
publications from our laboratory.13 14 26 Yet,
contrary to what is observed in noninjected Cx43 channels (eg, see
Reference 1414 ), only a minimal decrease in Gj was observed consequent to
acidification, even when the pHi dropped to 6.4.
Panel B of Figure 3
shows the average data from noninjected oocytes
(solid circles) and from Cx43-expressing oocytes that were injected
with the 17mer peptide (open circles). The average pKa of Cx43 after
injection of the peptide was 6.39±0.08 (n=7). This value was
statistically different from the one recorded from noninjected
oocytes (P<0.001). Although the average curve obtained
after the 17mer injection is clearly less steep than the one
recorded in the control condition, the Hill coefficients were not
statistically different, given the large scattering of the data within
groups (see Table 2
; see also "Discussion"). Interestingly, the
peptide prevented major changes in Gj within the range of
pHi values that can be observed in
ischemic tissue.10 12 It should be noted
that the data include one experiment in which there was normal
uncoupling after peptide injection. The reason for this result is
unclear. The possibility of error in the experimental procedure in that
case, though unlikely, cannot be discarded (see "Discussion").
|
The Ability of the 17mer Peptide to Prevent pH Gating Is
Sequence Specific
Results from other laboratories have shown that the ability of
proline-rich peptides to bind to their target molecules is highly
sensitive to the sequence of the peptide.27 We
determined whether the ability of the proline-rich peptide to block pH
gating was sequence specific. The sequence of peptide 271 to 287 of
Cx43 was randomized, although one restriction was maintained: no
obvious consensus sites for phosphorylation were
created (sequence shown in Table 1
). Average results obtained from 7
cell pairs after injection of this randomized peptide are shown in
Figure 4
. The pKa of Cx43 in the presence
of the random peptide was 6.67±0.02. This value was not different from
that obtained in the absence of the peptide or after water injection
(Figure 1A
). The results show that the amino acids contained within
region 271 to 287 of Cx43 need to be in the appropriate sequence to
prevent pH gating of wild-type Cx43 channels.
|
Effect of Shorter Peptides on pH Gating
To further evaluate the specificity of the 17mer peptide to alter
Cx43 regulation, two shorter peptides were tested. In one case, the
three amino acids at the N-terminal end of the 17mer peptide were
deleted (14mer of sequence PATPLSPMSPPGYK). In another case, the
17mer peptide was shortened from both the N-terminal and the CT ends
(11mer of sequence PTAPLSPMSPP). As shown in Figure 5
, neither peptide modified the pH
sensitivity of Cx43. This result is consistent with previous
studies, using short peptides of analogous primary structures, showing
that the sequences flanking proline-rich regions are essential for the
ability of the peptide to interact with its target
molecule.20 21 27
|
| Discussion |
|---|
|
|
|---|
Possible Mechanism of Action of the 17mer Peptide
The sequence of the 17mer peptide is the same as that of a region
of Cx43 that is important for pH regulation.17 We
propose that this peptide competes against the equivalent region of
Cx43 for binding to a target molecule that is required for
acidification-induced uncoupling. We further propose that the peptide
can bind the target molecule but fails to induce channel closure.
The average curves shown in Figure 3B
indicate that both the Hill
coefficient and the pKa were altered after injection of the 17mer
peptide. In a purely competitive reaction, no change in the Hill
coefficient would be expected. Our results may therefore suggest that
the effect of the peptide involves a mechanism of action beyond that of
pure competitive inhibition. However, the values of the Hill
coefficient have to be interpreted with caution. Indeed, rigorous
statistical analysis shows no significance (confidence level at
<0.05) in the observed shift in Hill coefficient. The latter results
from the scattering in Hill coefficient values within each group. It is
our experience that data scattering can drastically alter the slope of
the averaged curve. This is more pronounced when, as in this case, some
experiments show no acidification-induced change in Gj, whereas another
one shows a normal pH versus Gj curve. Our results show that the
peptide prevents pH gating, but we cannot draw conclusions as to the
type of inhibition (competitive, noncompetitive) that the peptide
exerts on the particle-receptor reaction.
The proline-rich region is known to be involved in the interaction of Cx43CT with other molecules. Warn-Cramer et al22 have shown that the same 17mer peptide here shown to block pH gating also acts as a substrate for MAPK.22 It is not known whether the ability of the peptide to block pH gating is related to its ability to act as a MAPK substrate. Although the 11mer and 14mer peptides still contained the putative MAPK consensus sites, shortening of the peptide may have altered its conformation, thus disrupting its ability to interact with the kinase. Further studies would be necessary to determine whether the shorter peptides are still suitable MAPK substrates.
Additional experiments show that the same 17mer peptide can inhibit the in vitro interaction between the CT domain of Cx43 and the SH3 domain of v-src.23 Whether pH gating involves the interaction of the CT domain with an SH3 domaincontaining protein is yet to be determined. The data obtained with the shorter peptides show that the ability of the peptide to block pH gating requires preservation of the amino acids that flank the proline-rich region. The latter is consistent with other results21 27 showing that small modifications in the sequence of proline-rich peptides can significantly alter their binding ability, despite preservation of the proline backbone.
In summary, the same primary structure (region 271 to 287 of Cx43) is involved in three seemingly independent regulatory mechanisms: MAPK-mediated phosphorylation, SH3 binding, and pH gating. We are not aware of biochemical evidence suggesting that MAPK is activated directly by acidification of the intracellular space, yet the regulation of this enzyme is highly complex, and acidification of the intracellular space causes significant changes in cell homeostasis. The possibility of indirect MAPK activation as a result of one of the many biochemical changes occurring in an oocyte after a drop in pH (eg, increase in intracellular calcium; see Reference 2828 ) cannot be discarded. On the other hand, the pH (or calcium) dependence of the interactions between an SH3 domain and its ligands has seldom been studied. Future experiments will be directed at characterizing whether these different processes intersect into a common molecular path.
pH Gating of Cx43: Is There an Intermediary Step?
Our laboratory has shown that truncation of the CT domain of Cx43
at amino acid 257 (mutant M257) interferes with pH
gating.13 pH gating of M257 can be partly rescued
by coexpression with mRNA coding exclusively for the CT
domain.24 On the basis of these and other
results,17 26 we have proposed that
acidification-induced uncoupling of Cx43 channels follows a
ball-and-chainlike model15 16 in which the CT
domain acts as a gating particle (a "ball") that, on acidification,
binds to its receptor and closes the channel. A question remains as to
whether the CT domain binds directly to another region of connexin (a
purely intramolecular interaction like the voltage gating of Shaker
channels16) or whether intermediary molecules are
involved. Evidence in favor of the latter has been recently reported in
a book chapter.29 The results presented in Figure 2
further support the possible participation of an intermediary molecule
in pH gating. We reason that if the interaction of the CT with the
channel pore were to involve only two molecules (the CT acting as the
particle and the pore region acting as a receptor), then adding an
excess of the CT domain should enhance the closing of the wild-type
channel. The data presented on Figure 2
indicate that this was
not the case. Instead, partial inhibition of pH gating was observed. As
shown in Figure 6A
, we suggest that pH
gating requires of an intermediary (asterisk) that interacts with the
CT domain (solid circle) to close the channel. An excess of free CT
would compete for the intermediary, thus preventing channel closure
(Figure 6B
). This model assumes that (1) the intermediary is
present only in limited supply and (2) even when bound to the
intermediary, free CT cannot close the channel in the presence of
wild-type CT. Further studies will be necessary to assess the validity
of the proposed model.
|
The diagram in Figure 6
illustrates the gating particle plugging an
open channel (analogous to the ShakerB ball-and-chain
model15,16). This is only a simplified
assumption. At this point, other mechanisms of channel closure (eg, a
change in CT conformation that pushes/pulls pore-lining transmembrane
domains) cannot be discarded, yet we suggest that this or any other
alternative model should be consistent with the proposition
that (1) the CT is an independent domain that interacts (directly or
indirectly) with another region of the channel to achieve channel
closure and (2) pH gating is not a simple bimolecular
reaction between the CT domain and the pore.
Limitations of the Study
Although extreme care was applied to control the amount of peptide
delivered into the oocyte, the actual final concentration inside the
cells may vary. First, the estimate of intracellular volume was based
on the assumption of a spherical oocyte of 1-mm diameter. However,
minor variations in diameter or internal volume between cells are
expected. Second, the estimation of injected volume is based on
measurements of the diameter of a hanging drop in the absence of a
cell, yet the actual volume delivered into the cell may change, given
the resistance provided by the intracellular space as well as the
possibility of minor backflow. Third, to ensure full recovery of
membrane integrity after the injection, we waited for 20 to 30 minutes
between the time of injection and that of the onset of
recording; the possibility of some peptide digestion during
this time cannot be discarded. Given these considerations, attempts at
performing full dose-response curves were deemed subject to significant
error. Thus, we chose to test a number of different peptides using an
estimated concentration that we found effective for the 17mer peptide.
Under these conditions, several peptides were found to be ineffective
at modulating pH gating. However, the possibility that some effect may
be obtained at larger concentrations cannot be discarded. Finally, we
did not detect significant differences in the Gj values measured at
normal pH between groups, yet minor effects could be masked by the
normal variability of Gj observed between experiments within any given
group. Given the demands of the experimental protocol, it was not
possible to measure the Gj before and after peptide injection at normal
pH for each individual experiment. Thus, the possibility that any of
these peptides could have minor effects on Gj at normal pH values
cannot be discarded.
Small Peptides as Tools to Study Gap Junction Function and
Regulation
Gap junctions have, so far, evaded the control of pharmacologists.
Molecules that target these channels with a reasonable degree of
specificity are not available. Although a number of agents close gap
junctions,30 several of them are known to be
quite nonspecific (eg, see Reference 3131 ). Recent reports have indicated
that a small 10-amino-acid peptide can enhance cardiac gap junction
conductance.32 Whether such a peptide acts by
interfering with the regulation of Cx43 remains to be determined.
Moreover, the above-mentioned study32 seems short
in rigorous statistical analysis, in the sense that no direct
comparison is presented to show that the average Gj values were
different before and after peptide exposure. The data in that study may
also be affected by the large Gj normally present between cardiac
myocytes.33
To our knowledge, this is the first report of a small molecule that can interfere with the chemical gating of gap junctions. However, a 17mer such as the one used in the present study may not be directly permeated through the cell membrane. Future efforts should be directed to the production of a peptide that can be incorporated into cells without the need for injection.
Whether chemical gating of gap junctions has a beneficial or a deleterious effect on the susceptibility to ischemia-induced cardiac arrhythmias has puzzled cardiac electrophysiologists for years. Although the present study represents an early step, it does open a door for the development of a new generation of agents: agents that could modulate the ability of gap junctions to close in response to physiological stimuli. The potential relevance of these agents as tools for studying the pathophysiology of ischemia-induced arrhythmias can be readily appreciated.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received September 15, 1997; accepted February 19, 1998.
| References |
|---|
|
|
|---|
2. Ewart JL, Cohen MF, Meyer RA, Huang GY, Wessels A, Gourdie RG, Chin AJ, Park SJ, Lazatin BO, Villabon S, Lo CW. Heart and neural tube defects in transgenic mice overexpressing the Cx43 gap junction gene. Development. 1997;124:12811292.[Abstract]
3.
Kleber AG, Riegger CB, Janse MJ. Electrical uncoupling
and increase of extracellular resistance after induction of
ischemia in isolated, arterially perfused rabbit
papillary muscle. Circ Res. 1987;61:271279.
4. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest. 1997;99:19911998.[Medline] [Order article via Infotrieve]
5. Delmar M, Liu S, Morley GE, Ek JF, Anumonwo JMB, Taffet SM. Toward a molecular model for the pH regulation of intercellular communication in the heart. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1995:135143.
6. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem. 1996;238:127.[Medline] [Order article via Infotrieve]
7. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons and intercellular communication. Annu Rev Biochem. 1996;65:475502.[Medline] [Order article via Infotrieve]
8. Lau AF, Kurata WE, Kanemitsu MY, Loo LWM, Warn-Cramer BJ, Eckhart W, Lampe PD. Regulation of connexin43 function by activated tyrosine protein kinases. J Bioenerg Biomembr. 1996;28:359368.[Medline] [Order article via Infotrieve]
9. Yeager M, Nicholson BJ. Structure of gap junction intercellular channels. Curr Opin Struct Biol. 1996;6:183192.[Medline] [Order article via Infotrieve]
10. Cascio WE, Johnson TA, Gettes LS. Electrophysiologic changes in ischemic ventricular myocardium, I: influence of ionic, metabolic and energy changes. J Cardiovasc Electrophysiol. 1995;6:10391062.[Medline] [Order article via Infotrieve]
11. Janse MJ, Opthof T. Mechanisms of ischemia-induced arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1995:489496.
12.
Janse MJ, Wit AL.
Electrophysiological mechanisms of
ventricular arrhythmias resulting from myocardial
ischemia and infarction. Physiol Rev. 1989;69:10491169.
13. Liu S, Taffet SM, Stoner L, Delmar M, Vallano ML, Jalife J. A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl terminal length. Biophys J. 1993;64:14221433.[Medline] [Order article via Infotrieve]
14. Morley GE, Taffet SM, Delmar M. Intramolecular interactions mediate the pH regulation of connexin43. Biophys J. 1996;70:12941302.[Medline] [Order article via Infotrieve]
15.
Armstrong CM, Bezanilla F. Inactivation of the sodium
channel, II: gating current experiments. J Gen Physiol. 1977;70:567590.
16.
Hoshi T, Zagotta WN, Aldrich RW. Biophysical and
molecular mechanisms of Shaker potassium channel inactivation.
Science. 1990;250:533538.
17. Ek-Vitorin JF, Calero G, Morley GE, Coombs W, Taffet SM, Delmar M. pH regulation of connexin43: molecular analysis of the gating particle. Biophys J. 1996;71:12731284.[Medline] [Order article via Infotrieve]
18. Adzhubei AA, Sternberg MJE. Left-handed polyproline II helices commonly occur in globular proteins. J Mol Biol. 1993;229:472493.[Medline] [Order article via Infotrieve]
19. Williamson MP. The structure and function of proline-rich regions in proteins. Biochem J. 1994;297:249260.
20. Cohen GB, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell. 1995;80:237248.[Medline] [Order article via Infotrieve]
21. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 1994;76:933945.[Medline] [Order article via Infotrieve]
22.
Warn-Cramer BJ, Lampe PD, Kurata WE, Kanemitsu MY, Loo
LWM, Eckhart W, Lau AF. Characterization of the
mitogen-activated protein kinase
phosphorylation sites on the connexin-43 gap junction
protein. J Biol Chem. 1996;271:37793786.
23.
Kanemitsu M, Loo Y, Simon LWM, Lau AF, Eckhart W.
Tyrosine phosphorylation of connexin43 by vSrc is
mediated by SH2 and SH3 domain interactions. J Biol
Chem. 1997;272:2282422831.
24. Morley GE, Ek-Vitorin JF, Taffet SM, Delmar M. Structure of connexin43 and its regulation by pHi. J Cardiovasc Electrophysiol. 1997;8:939951.[Medline] [Order article via Infotrieve]
25. Delmar M, Morley GE, Taffet SM. Molecular analysis of the pH regulation of the cardiac gap junction protein connexin43. In: Spooner PM, Joyner RW, Jalife J, eds. Discontinuous Conduction in the Heart. Armonk, NY: Futura Publishing Co; 1997.
26.
Ek JF, Delmar M, Perzova R, Taffet SM. Role of
Histidine 95 in pH gating of the cardiac gap junction protein
connexin43. Circ Res. 1994;74:10581064.
27.
Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quilliam
LA, Kay BK. Distinct ligand preferences of src homology 3 domains from
src, yes, ab1, cortactin, p53bp2, plc, crk and grb2. Proc Natl
Acad Sci U S A.. 1996;93:15401544.
28. Peracchia C, Wang X, Li L, Peracchia LL. Inhibition of calmodulin expression prevents low-pH-induced gap junction uncoupling in Xenopus oocytes. Pflugers Arch. 1996;431:379387.[Medline] [Order article via Infotrieve]
29. Nicholson BJ, Zhou L, Cao F, Zhu H, Chen Y. Diverse molecular mechanisms of gap junction channel gating. In: Werner R, ed. Gap Junctions. Amsterdam, Netherlands: IOS Press; 1998:37.
30.
Valiunas V, Bukauskas F, Weingart R. Conductances and
selective permeability of connexin43 gap junction channels examined in
neonatal rat heart cells. Circ Res. 1997;80:708719.
31.
Niggli E, Rudisuli A, Maurer P, Weingart R. Effect of
general anesthetics on current flow across membranes in guinea pig
myocytes. Am J Physiol. 1989;256:C273C281.
32. Muller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol. 1997;327:6572.[Medline] [Order article via Infotrieve]
33. Wilders R, Jongsma HJ. Limitations of the dual voltage clamp method in assaying conductance and kinetics of gap junction channels. Biophys J. 1992;63:942953.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
R. Lewandowski, K. Procida, R. Vaidyanathan, W. Coombs, J. Jalife, M. S. Nielsen, S. M. Taffet, and M. Delmar RXP-E: A Connexin43-Binding Peptide That Prevents Action Potential Propagation Block Circ. Res., August 29, 2008; 103(5): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Hirst-Jensen, P. Sahoo, F. Kieken, M. Delmar, and P. L. Sorgen Characterization of the pH-dependent Interaction between the Gap Junction Protein Connexin43 Carboxyl Terminus and Cytoplasmic Loop Domains J. Biol. Chem., February 23, 2007; 282(8): 5801 - 5813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shibayama, R. Lewandowski, F. Kieken, W. Coombs, S. Shah, P. L. Sorgen, S. M. Taffet, and M. Delmar Identification of a Novel Peptide That Interferes With the Chemical Regulation of Connexin43 Circ. Res., June 9, 2006; 98(11): 1365 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Sinovas, D. Garcia-Dorado, P. Pina, M. Ruiz-Meana, and J. Soler-Soler Effect of sarcolemmal rupture on myocardial electrical impedance during oxygen deprivation Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1396 - H1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Sorgen, H. S. Duffy, P. Sahoo, W. Coombs, M. Delmar, and D. C. Spray Structural Changes in the Carboxyl Terminus of the Gap Junction Protein Connexin43 Indicates Signaling between Binding Domains for c-Src and Zonula Occludens-1 J. Biol. Chem., December 24, 2004; 279(52): 54695 - 54701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium J. Physiol., August 15, 2004; 559(1): 245 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bao, G. A. Altenberg, and L. Reuss Mechanism of regulation of the gap junction protein connexin 43 by protein kinase C-mediated phosphorylation Am J Physiol Cell Physiol, March 1, 2004; 286(3): C647 - C654. [Abstract] [Full Text] |
||||
![]() |
D. Garcia-Dorado, A. Rodriguez-Sinovas, and M. Ruiz-Meana Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion Cardiovasc Res, February 15, 2004; 61(3): 386 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Duffy, P. L. Sorgen, M. E. Girvin, P. O'Donnell, W. Coombs, S. M. Taffet, M. Delmar, and D. C. Spray pH-Dependent Intramolecular Binding and Structure Involving Cx43 Cytoplasmic Domains J. Biol. Chem., September 20, 2002; 277(39): 36706 - 36714. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Doble, P. Ping, and E. Kardami The {epsilon} Subtype of Protein Kinase C Is Required for Cardiomyocyte Connexin-43 Phosphorylation Circ. Res., February 18, 2000; 86(3): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stergiopoulos, J. L. Alvarado, M. Mastroianni, J. F. Ek-Vitorin, S. M. Taffet, and M. Delmar Hetero-Domain Interactions as a Mechanism for the Regulation of Connexin Channels Circ. Res., May 28, 1999; 84(10): 1144 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Hossain, A. B. Jagdale, P. Ao, A. Kazlauskas, and A. L. Boynton Disruption of Gap Junctional Communication by the Platelet-derived Growth Factor Is Mediated via Multiple Signaling Pathways J. Biol. Chem., April 9, 1999; 274(15): 10489 - 10496. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Homma, J. L. Alvarado, W. Coombs, K. Stergiopoulos, S. M. Taffet, A. F. Lau, and M. Delmar A Particle-Receptor Model for the Insulin-Induced Closure of Connexin43 Channels Circ. Res., July 13, 1998; 83(1): 27 - 32. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |